Skip to content

Spectra Optia

Spectra Optia® Therapeutic Apheresis System

The Spectra Optia system is an industry-leading therapeutic apheresis, cell processing and cell collection platform. The system allows operators to spend more time focusing on patient care. This advanced system uses continuous-flow centrifugation and optical detection technology, providing operators the ability to perform a wide variety of apheresis procedures on a single platform.

Easy to Use

  1. Control procedures with real-time interface monitoring, interpretation and adjustment with the automated interface management (AIM) system
  2. Minimize training and reduce inventory and storage with tubing sets designed for multiple procedure types
  3. Easily move and store the Spectra Optia system with its compact and stable design, including a collapsible monitor and IV pole

Focus on Patient, Not Technology

  1. Focus on patient comfort and safety with optimized fluid balance, customized anticoagulant infusion management and tubing sets with low extracorporeal volume
  2. Access procedure data quickly and easily on the intuitive touch screen while reducing the need for manual calculations


No known contraindications for the system’s use, except for those associated with all automated apheresis systems. The infusion of certain solutions and replacement fluids may be contraindicated in some patients

Possible patient reactions.

Anxiety, headache, light-headedness, digital and/or facial paresthesia, fever, chills, hematoma, hyperventilation, nausea and vomiting, syncope (fainting), urticaria, hypotension and allergic reactions.

Reactions to transfused blood products can include;

Fever, circulatory overload, shock, allergic reactions, alloimmunization, graft-versus-host disease and transmission of infection.

Restricted to prescription use only

Operators must be familiar with the system’s operating instructions

Procedures must be performed by qualified medical personnel

A supervisory practitioner may supervise from a physician office or other nonhospital space that is not officially part of the hospital campus as long as he or she remains immediately available2

  1. AABB (ed.), et al., Circular of Information for the Use of Human Blood and Blood Components. 2006, tenth edition, Council of Europe Publishing, Seattle, WA.
  2. American Society for Apheresis, “Guidelines for Documentation of Therapeutic Apheresis Procedures in the Medical Record by Apheresis Physicians.” Journal of Clinical Apheresis 2007; 22 (3): 183.